Healthcare Professionals

Carcinoid tumors, which have their origins in neuroendocrine cells, can release highly bioactive chemicals. The elevated levels of these chemicals produced when the tumors metastasize result in the symptoms known as carcinoid syndrome.

Carcinoid syndrome is associated with significant morbidity and mortality. However, its symptoms are so vague and nonspecific that the diagnosis is frequently missed or substantially delayed. Biochemical monitoring is key to both diagnosis and ongoing follow-up of the condition. This section provides information about carcinoid syndrome, including: